Abstract
Introduction Non-communicable diseases (NCDs) are still a major public health problem in Indonesia. Studies have shown that risk factors of NCDs were associated with coronavirus disease 2019 (COVID-19) severity and mortality. However, it is unclear whether NCD risk factors are also risks for new COVID-19 infection. This study aimed to obtain the NCD risk profiles among university’s employees and its association with COVID-19 infection.
Methods A cross-sectional study was conducted in October 2021. Participants were administrative employees of Universitas Indonesia (UI), Depok City, West Java. Assessment of NCDs risk factors was based on the World Health Organization STEPwise approach to NCD risk factor surveillance (WHO STEPS). Demographics, working and medical history data were obtained electronically by using a Google Form. Physical and laboratory examination were done in the Integrated Post for NCDs. Risks were expressed as adjusted odds ratio (ORadj) and 95% confidence interval (CI) in multivariate analyses.
Results A total of 613 employees were enrolled. Men were predominant (54.8%) and about 36% of them work in shift as security personnel. About 66.7% were overweight or obese and 77.8% had hypertension. There were 138 (22.8%) employees who had COVID-19 infection. Nearly all (95.6%) have completed COVID-19 vaccination. At-risk waist circumference (ORadj 1.74, 95% CI 1.17-2.60, p=0.007) and total cholesterol level of 200-239 mg/dL (ORadj 2.24, 95% CI 1.15-4.33, p=0.017) were independent risk factors, but shift work (ORadj 0.54, 95% CI 0.24-0.84, p=0.006) was protective to COVID-19 infection.
Conclusion The prevalence of NCDs risk factors among university administrative employees was high, increasing the risk for COVID-19 infection. A behavioral intervention program to manage the NCD risk factors at the university level is urgently needed according to the Health Promoting University framework.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ISW received funding from the Ministry of Education, Culture, Research and Technology of the Republic of Indonesian (grant number: NKB-358/UN2.RST/HKP.05.00/2021) to conduct this study. The funder had no role in the study conception, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Ethic Committee of the Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital granted the ethical approval for this work (No. KET-1006/UN2.F1/ETIK/PPM.00.02/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files